Global Cosmetic Grade Nicotinamide Mononucleotide Hydride (NMNH) Market Growth 2025-2031

The global Cosmetic Grade Nicotinamide Mononucleotide Hydride (NMNH) market size is predicted to grow from US$ 38.9 million in 2025 to US$ 57.8 million in 2031; it is expected to grow at a CAGR of 6.8% from 2025 to 2031.

Cosmetic Grade Nicotinamide Mononucleotide Hydride (NMNH) is an ingredient designed for use in cosmetic formulations with high purity and safety standards. As a precursor to nicotinamide adenine dinucleotide (NAD+), this ingredient can help improve the skin's energy metabolism, promote cell repair, and enhance the skin's overall health and vitality. It is commonly used in anti-aging, moisturizing and skin beauty products. Consumers can expect better skin care results and a rejuvenated skin experience when using cosmetics containing NMNH.

United States market for Cosmetic Grade Nicotinamide Mononucleotide Hydride (NMNH) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Cosmetic Grade Nicotinamide Mononucleotide Hydride (NMNH) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Cosmetic Grade Nicotinamide Mononucleotide Hydride (NMNH) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Cosmetic Grade Nicotinamide Mononucleotide Hydride (NMNH) players cover Hygieia Biotech, EffePharm, ChromaDex Corp., Bontac Bio-Engineering (Shenzhen) Co., Ltd., Bonerge Lifescience, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Cosmetic Grade Nicotinamide Mononucleotide Hydride (NMNH) Industry Forecast” looks at past sales and reviews total world Cosmetic Grade Nicotinamide Mononucleotide Hydride (NMNH) sales in 2024, providing a comprehensive analysis by region and market sector of projected Cosmetic Grade Nicotinamide Mononucleotide Hydride (NMNH) sales for 2025 through 2031. With Cosmetic Grade Nicotinamide Mononucleotide Hydride (NMNH) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cosmetic Grade Nicotinamide Mononucleotide Hydride (NMNH) industry.

This Insight Report provides a comprehensive analysis of the global Cosmetic Grade Nicotinamide Mononucleotide Hydride (NMNH) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cosmetic Grade Nicotinamide Mononucleotide Hydride (NMNH) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cosmetic Grade Nicotinamide Mononucleotide Hydride (NMNH) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cosmetic Grade Nicotinamide Mononucleotide Hydride (NMNH) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cosmetic Grade Nicotinamide Mononucleotide Hydride (NMNH).

This report presents a comprehensive overview, market shares, and growth opportunities of Cosmetic Grade Nicotinamide Mononucleotide Hydride (NMNH) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
>95%
>99%
＞99.5%

Segmentation by Application:
Cream
Lotion
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Hygieia Biotech
EffePharm
ChromaDex Corp.
Bontac Bio-Engineering (Shenzhen) Co., Ltd.
Bonerge Lifescience
Hebei Zhuanglai Chemical Trading Co.,Ltd.
Xi'an Core Pure Co., Ltd
Provita Biotech Co., Ltd.
Maintain Biotech Co.,Ltd
Bicells Science Ltd.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cosmetic Grade Nicotinamide Mononucleotide Hydride (NMNH) market?

What factors are driving Cosmetic Grade Nicotinamide Mononucleotide Hydride (NMNH) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Cosmetic Grade Nicotinamide Mononucleotide Hydride (NMNH) market opportunities vary by end market size?

How does Cosmetic Grade Nicotinamide Mononucleotide Hydride (NMNH) break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.